Lexicon Pharmaceuticals And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders at Lexicon Pharmaceuticals, Avalo Therapeutics, and PEDEVCO have recently made significant stock purchases. Lexicon announced a $125 million public offering and concurrent private placement, Avalo posted a narrower-than-expected quarterly loss, and PEDEVCO expanded into Wyoming D-J Basin Codell Play.
June 21, 2023 | 12:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalo Therapeutics' 10% owner Caissa Capital Management Ltd acquired 8,160 shares at $3.88 each, after the company posted a narrower-than-expected quarterly loss.
The insider purchase of 8,160 shares by Avalo Therapeutics' 10% owner indicates confidence in the company's prospects. The recent posting of a narrower-than-expected quarterly loss is a positive development, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Lexicon Pharmaceuticals' President and CFO purchased 12,000 shares at $2.33 each, following the announcement of a $125 million public offering and concurrent private placement.
The insider purchase of 12,000 shares by Lexicon Pharmaceuticals' President and CFO indicates confidence in the company's prospects. The recent announcement of a $125 million public offering and concurrent private placement is a positive development, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
PEDEVCO's 10% owner SGK 2018 REVOCABLE TRUST acquired 130,453 shares at $0.89 each, following the company's announcement of expansion into Wyoming D-J Basin Codell Play.
The insider purchase of 130,453 shares by PEDEVCO's 10% owner indicates confidence in the company's prospects. The recent announcement of expansion into Wyoming D-J Basin Codell Play is a positive development, which could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100